Icell Kealex Therapeutics' Incubator/Accelerator Round

Icell Kealex Therapeutics raised a round of funding on March 02, 2016. Investors include JLabs.

Icell Kealex Therapeutics is developing a T-cell engager-armed virus for the treatment of solid tumors.…

Articles about Icell Kealex Therapeutics' Incubator/Accelerator Round: